NCT06500598|Unknown
Compassionate Use of Evinacumab
1 other identifier
R1500-Evinacumab
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredJul 2024
Brief Summary
Provide compassionate use of evinacumab
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2024
Completed7 days until next milestone
First Posted
Study publicly available on registry
July 15, 2024
CompletedLast Updated
October 28, 2025
Status Verified
October 1, 2025
First QC Date
July 8, 2024
Last Update Submit
October 24, 2025
Conditions
Interventions
EvinacumabDRUG
Also known as: REGN1500, EVKEEZA®
Sponsors & Collaborators
MeSH Terms
Conditions
HypertriglyceridemiaHyperlipoproteinemia Type III
Interventions
evinacumab
Condition Hierarchy (Ancestors)
HyperlipidemiasDyslipidemiasLipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesLipid Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHyperlipoproteinemias
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2024
First Posted
July 15, 2024
Last Updated
October 28, 2025
Record last verified: 2025-10